Identification of chemoresistance‐related mRNAs based on gemcitabine‐resistant pancreatic cancer cell lines

Gemcitabine (GEM) alone and GEM‐based chemotherapy are the preferred regimens for treating advanced unresectable and metastatic pancreatic cancer (PC). However, these treatments have limited efficacy due to acquired resistance of cancer cells to chemotherapy, the mechanisms of which are not fully un...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiarong, Zhang, Linshi, Zheng, Huilin, Ge, Wenhao, Huang, Yu, Yan, Yingcai, Zhou, Xiaohu, Zhu, Wei, Kong, Yang, Ding, Yuan, Wang, Weilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997050/
https://www.ncbi.nlm.nih.gov/pubmed/31823522
http://dx.doi.org/10.1002/cam4.2764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997050/
https://www.ncbi.nlm.nih.gov/pubmed/31823522
http://dx.doi.org/10.1002/cam4.2764

Ejemplares similares